MEI Pharma, Inc. financial data

Symbol
MEIP on Nasdaq
Industry
Pharmaceutical Preparations
Location
11455 El Camino Real, Suite 250, San Diego, California
State of incorporation
Delaware
Fiscal year end
June 30
Former names
MARSHALL EDWARDS INC (to 6/6/2012)
Latest financial report
10-Q - Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 691 % +14.1%
Debt-to-equity 71.8 % -72.5%
Return On Equity 48 %
Return On Assets 28 %
Operating Margin 33.6 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.66M shares 0%
Common Stock, Shares, Outstanding 6.66M shares 0%
Entity Public Float 31.8M USD -91%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 6.66M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 6.66M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 66.8M USD +13.6%
Research and Development Expense 15.2M USD -78.8%
General and Administrative Expense 29.1M USD +0.66%
Costs and Expenses 44.3M USD -56%
Operating Income (Loss) 22.4M USD +40%
Nonoperating Income (Expense) 3.71M USD -26.3%
Net Income (Loss) Attributable to Parent 26M USD +40.9%
Earnings Per Share, Basic 3.92 USD/shares +40.9%
Earnings Per Share, Diluted 3.92 USD/shares +40.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.37M USD -73.1%
Cash, Cash Equivalents, and Short-term Investments 56.6M USD -49.5%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 59.4M USD -50.7%
Property, Plant and Equipment, Net 1.06M USD -22.5%
Operating Lease, Right-of-Use Asset 10.8M USD -12.2%
Assets 71.3M USD -46.9%
Accounts Payable, Current 3.18M USD -27.6%
Employee-related Liabilities, Current 2.64M USD
Accrued Liabilities, Current 5.39M USD -66.9%
Liabilities, Current 9.62M USD -59.3%
Operating Lease, Liability, Noncurrent 10.6M USD -9.02%
Liabilities 20.2M USD -79.7%
Retained Earnings (Accumulated Deficit) -370M USD +6.61%
Stockholders' Equity Attributable to Parent 51M USD +48.5%
Liabilities and Equity 71.3M USD -46.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.5M USD -25.1%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 4.96M USD -63.9%
Common Stock, Shares Authorized 226M shares 0%
Common Stock, Shares, Issued 6.66M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Deferred Tax Assets, Valuation Allowance 76.2M USD +10.1%
Deferred Tax Assets, Gross 76.2M USD +10.1%
Operating Lease, Liability 11.7M USD -10.6%
Depreciation 86K USD -11.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 14.6M USD -13.7%
Property, Plant and Equipment, Gross 2.35M USD
Operating Lease, Liability, Current 1.05M USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.48M USD +29.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.91M USD -18.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.96M USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.55M USD +2.99%
Deferred Tax Assets, Operating Loss Carryforwards 34.5M USD +16.7%
Preferred Stock, Shares Issued 100K shares 0%
Preferred Stock, Shares Authorized 100K shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.72M USD +6.43%
Operating Lease, Payments 2.32M USD +3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 87K USD -12.1%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%